This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* AMI in Elderly Patients
* Primary PTCA as a Reperfusion...
* Primary PTCA Vs Lysis...
* Senior PAMI Trial
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
Guest faculty, Cindy Grines, MD indicates the she receives research/grant support from
Amersham Health, Guidant, Eli Lilly, Boston Scientific, Berlex, Cardiovascular Research
Foundation, CV Therapeutics, Innercool Therapies, Takeda Pharmaceuticals and Cordis. Dr.
Grines is also a consultant for Innercool Therapies, Pfizer, Sanofi-Synthelabo, Inc.,
Bristol-Meyers Squibb/Sanofi Pharmaceuticals Partnership and Glaxo-Smith Kline Global
Cardiovascular Advisory Board
|
|